OLSON ERIC R (Chief Scientific Officer) reported 1 transaction at SYROS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/4/2022ACC: 0001209191-22-022503
Officer· Chief Scientific Officer
Since Feb 2019
-27.27K
Net shares
Net seller
$30.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
27.27K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−27.27K
Price / share
$1.12
Trade value
$30.54K
% of position
31.3%
4/1/2022
87K→59.73K
Total
Net shares
−27.27K
Net value
-$30.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2022 | F · Tax Withholding | −27.27K | $1.12 | $30.54K | 31.3% | 87K | 59.73K |
| Total | −27.27K | -$30.54K | ||||||
Derivative Transactions0
No derivative transactions reported